The controlled aggregation and tunable viscosity of nanostructured lipid carrier dispersions

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 482, Issue , 2015, Pages 138-147

  Yang, Yihui ^a   Corona, Alessandro ^b   Bhatia, Surita R ^c,d   Henson, Michael A ^a  

^a University of Massachusetts   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Nanostructured lipid carriers; Particle aggregation; Rheology; Solid lipid nanoparticles

Indexed keywords

AGGREGATES; CHEMICAL BONDS; DISPERSIONS; ELASTICITY; LIQUIDS; NANOPARTICLES; OIL SHALE; RHEOLOGY; SURFACE ACTIVE AGENTS; SUSPENSIONS (FLUIDS); VISCOELASTICITY; VISCOSITY;

INTERCONNECTED NETWORK; LIPOPHILIC COMPOUNDS; NANOSTRUCTURED LIPID CARRIERS; PARTICLE AGGREGATION; POLYMORPHIC TRANSFORMATION; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; SUSPENSION VISCOSITY;

AGGLOMERATION;

LIPID; NANOCARRIER; SURFACTANT; TRIOLEIN; TRISTEARIN;

ARTICLE; DISPERSION; FLOW KINETICS; MATHEMATICAL MODEL; NANOSTRUCTURED LIPID CARRIER DISPERSION; OSCILLATION; PRIORITY JOURNAL; SHEAR RATE; VISCOMETRY; VISCOSITY;

EID: 84929151547     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2015.04.036     Document Type: Article

References (48)

1. Mehnert W., Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47:165-196.
2. Weiss J., Decker E., McClements D.J., Kristbergsson K., Helgason T., Awad T. Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophys. 2008, 3:146-154.
3. Müller R.H., Mehnert W., Lucks J.-S., Schwarz C., Zur Mühlen A., Meyhers H., Freitas C., Rühl D. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995, 41:62-69.
4. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
5. Siekmann B., Westesen K. Sub-micron sized parenteral carrier systems based on solid lipid. Pharm. Pharmacol. Lett. 1992, 1:123-126.
6. Jenning V., Schäfer-Korting M., Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Release 2000, 66:115-126.
7. Wissing S.A., Kayser O., Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 2004, 56:1257-1272.
8. Joshi M.D., Muller R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 2009, 71:161-172.
9. Siekmann B., Westesen K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf. B: Biointerfaces 1994, 3:159-175.
10. Helgason T., Awad T.S., Kristbergsson K., McClements D.J., Weiss J. Influence of polymorphic transformations on gelation of tripalmitin solid lipid nanoparticle suspensions. J. Am. Oil. Chem. Soc. 2008, 85:501-511.
11. Westesen K., Bunjes H., Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 1997, 48:223-236.
12. Bunjes H., Steiniger F., Richter W. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 2007, 23:4005-4011.
13. Yang Y., Corona A., Henson M.A. Experimental investigation and population balance equation modeling of solid lipid nanoparticle aggregation dynamics. J. Colloid Interface Sci. 2012, 374:297-307.
14. Müller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242:121-128.
15. Awad T.S., Helgason T., Weiss J., Decker E.A., McClements D.J. Effect of omega-3 fatty acids on crystallization, polymorphic transformation and stability of tripalmitin solid lipid nanoparticle suspensions. Cryst. Growth Des. 2009, 9:3405-3411.
16. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54(Suppl.):S131-S155.
17. Dingler A., Blum R.P., Niehus H., Müller R.H., Gohla S. Solid lipid nanoparticles (SLNTM/LipopearlsTM) a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J. Microencapsul. 1999, 16:751-767.
18. Saupe A., Wissing S.A., Lenk A., Schmidt C., Muller R.H. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) - structural investigations on two different carrier systems. Bio-med. Mater. Eng. 2005, 15:393-402.
19. Muller R.H., Shegokar R., Keck C.M. 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr. Drug Discov. Technol. 2011, 8:207-227.
20. Pardeike J., Hommoss A., Muller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009, 366:170-184.
21. Sawant K.K., Dodiya S.S. Recent advances and patents on solid lipid nanoparticles. Recent. Pat. Drug Deliv. Formul. 2008, 2:120-135.
22. Das S., Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011, 12:62-76.
23. Iqbal M.A., Md S., Sahni J.K., Baboota S., Dang S., Ali J. Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target 2012, 20:813-830.
24. Puglia C., Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin. Drug Deliv. 2012, 9:429-441.
25. Araujo J., Nikolic S., Egea M.A., Souto E.B., Garcia M.L. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf. B: Biointerfaces 2011, 88:150-157.
26. Pardeike J., Schmidt C., Volz I., Muller R.H. Nanostructured lipid carriers as delivery system for the phopholipase A2 inhibitors PX-18 and PX-13 for dermal application. Pharmazie 2011, 66:357-361.
27. Hommoss A. Preservative system development for argan oil-loaded nanostructured lipid carriers. Pharmazie 2011, 66:187-191.
28. Vieira D.B., Carmona-Ribeiro A.M. Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro. J. Nanobiotechnol. 2008, 6:6.
29. Souto E.B., Muller R.H. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J. Microencapsul. 2006, 23:377-388.
30. Yang Y., Corona Iii A., Schubert B., Reeder R., Henson M.A. The effect of oil type on the aggregation stability of nanostructured lipid carriers. J. Colloid Interface Sci. 2014, 418:261-272.
31. Schwarz J.C., Weixelbaum A., Pagitsch E., Löw M., Resch G.P., Valenta C. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties. Int. J. Pharm. 2012, 437:83-88.
32. Lippacher A., Müller R.H., Mäder K. Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int. J. Pharm. 2000, 196:227-230.
33. Lippacher A., Müller R.H., Mäder K. Semisolid SLN ™ dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm. 2002, 53:155-160.
34. Lippacher A., Müller R.H., Mäder K. Liquid and semisolid SLN ™ dispersions for topical application: rheological characterization. Eur. J. Pharm. Biopharm. 2004, 58:561-567.
35. Silva A.C., Santos D., Ferreira D.C., Souto E.B. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie 2009, 64:177-182.
36. ®) suspended in a viscoelastic medium. Pharmazie 2005, 60:671-673.
37. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations. Int. J. Cosmet. Sci. 2004, 55:463-471.
38. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 2004, 58:83-90.
39. Joshi M., Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of Valdecoxib. Drug Dev. Ind. Pharm. 2006, 32:911-918.
40. Joshi M., Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 2008, 346:124-132.
41. Junyaprasert V.B., Teeranachaideekul V., Souto E.B., Boonme P., Müller R.H. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int. J. Pharm. 2009, 377:207-214.
42. de Rooij R., Potanin A.A., van den Ende D., Mellema J. Steady shear viscosity of weakly aggregating polystyrene latex dispersions. J. Chem. Phys. 1993, 99:9213-9223.
43. Potanin A.A., De Rooij R., Van den Ende D., Mellema J. Microrheological modeling of weakly aggregated dispersions. J. Chem. Phys. 1995, 102:5845-5853.
44. Bunjes H., Koch M.H.J. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J. Control. Release 2005, 107:229-243.
45. Eccleston G.M., Barry B.W., Davis S.S. Correlation of viscoelastic functions for pharmaceutical semisolids: comparison of creep and oscillatory tests for oil-in-water creams stabilized by mixed emulsifiers. J. Pharm. Sci. 1973, 62:1954-1961.
46. Picout D.R., Ross-Murphy S.B. Rheology of biopolymer solutions and gels. ScientificWorldJournal 2003, 3.
47. 2 nanoparticle suspensions. Mater. Sci. Eng. A 2003, 355:186-192.
48. Soos M., Sefcik J., Morbidelli M. Investigation of aggregation, breakage and restructuring kinetics of colloidal dispersions in turbulent flows by population balance modeling and static light scattering. Chem. Eng. Sci. 2006, 61:2349-2363.